Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for preventing recurrent gestational diabetes
NCT02394158Phase 4Unknown
- Sponsor
- Imperial College London
- Start
- Jan 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gestational diabetes mellitus (GDM) comparing Metformin with Placebo (2 arms). Primary endpoint: Development of Gestational Diabetes. Status: unknown.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT02394158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02394158.